A Rise in CA19-9 Test Result

Li Liu, MD
Last Modified: November 1, 2001

Dear OncoLink "Ask the Experts,"
More than 4 years after an operation for gastric cancer my CA19-9 marker has gone up. Testing does not reveal any clue as to why this has happened. What is CA19-9 and why might this be happening?  
Thank you.

Li Liu, MD, Editorial Assistant for OncoLink, responds:

Dear JR,
Thank you for your interest and question.

Carbohydrate antigen 19-9 (CA19-9) is a glycoprotein of normal cells. It has been used in monitoring of malignancies of the gastrointestinal tract. Recently it was used for possible expression in gynecologic malignancies along with other tumor markers, such as carcinoembryonic antigen (CEA) and CA-125. However, CA19-9 has a relatively low sensitivity and also is non-specific. For male patients, there was one case report of elevated serum CA19-9 associated with prostate cancer. In this case, serum PSA would be very helpful.

Other non-malignant diseases have also been reported to be associated with high level serum CA19-9. These include: interstitial pneumonia; interstitial pulmonary fibrosis; mediastinal bronchogenic cyst; splenic cyst; and auto-immune hepatitis.

Some oncologists believe that one of the general principles of cancer treatment is to treat the cancer not number.

You should discuss your treatment with your oncologist.


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

AACR: Biomarker Panel Beats CA 19-9 for ID'ing Pancreatic Cancer

May 21, 2014

Panel distinguishes early cancer from healthy controls, chronic pancreatitis, benign cysts

CA 19-9, Ultrasound Feasible for Pancreatic Cancer Detection

Aug 2, 2011

Protocol feasible for detecting early stage pancreatic adenocarcinoma in high-risk patients

Most Parents Communicate BRCA Test Results to Offspring

Jan 10, 2012

Initial offspring responses most frequently neutral or relief; minority report distress or concern